Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Keros completes dosing of planned cohorts in phase I study of KER-047

Aug. 6, 2020

Novel humanized platelet mouse model predicts efficacy of experimental antiplatelet drugs

Aug. 5, 2020

Data presented for factor XIa inhibitor milvexian in thrombosis models

Aug. 4, 2020

Src SH3 domain: an antithrombotic target without compromising homeostasis

July 31, 2020

Novel mouse model of AAA with intraluminal thrombus

July 30, 2020

INSERM presents preclinical data for single-domain antibody PS-003

July 28, 2020

FRSW-107 demonstrates extended half-life in patients with hemophilia A

July 28, 2020

FDA allows initiation of clinical trials for desidustat in chemotherapy-induced anemia

July 27, 2020

Discovery and preclinical evaluation of novel direct FXIa inhibitor, ONO-1600586

July 27, 2020

MPI-8 reduces thrombosis without increased bleeding in vivo

July 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...